In women with suspected preeclampsia, high discriminatory performance or strong likelihood ratios (LRs) have been demonstrated for PlGF for combined adverse maternal and fetal outcomes (usually the need for delivery with pre-eclampsia within 7–14 days) [10, 14–18]; however there are limited studies reporting on solely maternal outcomes [18–22]. The gene discussed is PGF; the disease is preeclampsia.